Quebec
SmartCare
Consortium

Novartis Pharmaceuticals Canada Inc.

​

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development.

 

The participation of Novartis in the Quebec SmartCare Consortium aligns with many Novartis strategic goals and our overall desire to become the most valued partner to the oncology healthcare community. To do so, we are focused on the use of novel digital technologies, integrated and sustainable solutions to breakdown healthcare data siloes and, ultimately, empower patients to the fullest in their disease management. In addition, this will create efficiencies for clinicians and enable researchers access to enriched data, overall improving general Canadian patients outcomes.

​

​